PRE-MARKET CHINESE STOCKS NEWS: Earnings updates including from WuXi AppTec and ZTE Corporation

China Gold International Resources (2099 HK) - Co. reaffirmed FY26 production guidance and resumed mining operations at its CSH mine. (Newswires)

China XLX Fertiliser (1866 HK) - Co. Q3 (CNY) net rose 8% Y/Y to 217mln, rev. rose 38% Y/Y to 7.31bln. (Newswires)

CIMC Enric (3899 HK) - Co. Q3 (CNY) net rose 47.1% Y/Y to 300mln, rev. rose 13.5% Y/Y to 7.64bln. (Newswires)

HSBC Holdings (5 HK) - Co.'s asset management unit announced plans to absorb Hang Seng Investment Management. (Newswires)

Huafa Properties (600325 CH) - Co. is reportedly seeking to extend repayments on some of its debt. (Bloomberg)

InnoCare Pharma (9969 HK) - Co. Q3 (CNY) adjusted net 399mln, rev. rose 150.6% Y/Y to 962mln. (Newswires)

Meituan (3690 HK) - Co. launched an offering of CNH-denominated bonds with five- and ten-year maturities, with initial price guidance of approximately 2.9% and 3.6%, respectively. (Newswires)

Sands China (1928 HK) - Co. proposed issuing senior notes, with terms yet to be determined, to redeem USD 700mln of 2027 notes, repay its 2024 SCL revolving facility and fund general corporate purposes. (Newswires)

Sino Biopharmaceutical (1177 HK) - Co. announced that TQ-A3334 and TQA3605 received breakthrough therapy designations from China's CDE. (Newswires)

SSY Group (2005 HK) - Co. 9M (HKD) net rose 15.3% Y/Y to 460mln, rev. rose 13.5% Y/Y to 3.52bln. (Newswires)

Wanhua Chemical (600309 CN) - Co. Q3 (CNY) net 5.60bln (exp. 5.08bln), rev. 66.6bln (exp. 61.8bln). (Newswires)

WuXi AppTec (2359 HK) - Co. 9M (CNY) net 8.32bln (exp. 8.25bln), rev. 16.6bln (exp. 15.8bln), raised FY26 revenue guidance to CNY 61.0-61.9bln (prev. 58.5-60.5bln) and adjusted capex guidance to CNY 8.0-8.5bln (prev. 7.5-8.5bln). (Newswires)

Yue Yuen Industrial (551 HK) - Co. expects 9M net profit to fall 50-55% Y/Y from USD 279mln. (Newswires)

ZTE Corporation (000063 CN) - Co. Q3 (CNY) net rose 394.5% Y/Y to 1.31bln, rev. rose 34.0% Y/Y to 38.8bln. (Newswires)

This is the standard pre-open China and Hong Kong news sweep, and precedents of this kind are treated as a positioning grid rather than a single signal: the index rarely moves on the bundle, but single-name gaps at the open tend to cluster where the print deviated furthest from expectation or where guidance was changed. Here the actionable threads are of three distinct types. First, clean beats with raised guidance (WuXi AppTec lifting FY26 revenue, Wanhua topping both lines), which in past rounds of this kind have set the tone for their respective subsectors, contract research and chemicals, via peer read-across rather than the name alone. Second, credit events: Huafa reportedly seeking debt extensions extends the pattern of state-linked developers managing maturities through negotiation rather than default, while the Sands China refinancing and the Meituan dim sum offering are liability-management moves of the sort that matter for the offshore credit complex and the CNH curve more than for the equities themselves. Third, sector tells: a CDE breakthrough designation for Sino Biopharm fits the recurring pattern of Chinese biotech names trading on pipeline headlines, and the ZTE profit jump warrants a check of the base, since percentage moves of that size off a depressed prior period have historically flattered the headline number. The follow-ons are the opens of the named lines, any read-across into unlisted peers, and whether the Huafa report draws confirmation or denial, which is the usual fork in developer credit stories.